Label: PYRANTEL PAMOATE tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated January 2, 2018

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active Ingredient (in each tablet)

    Pyrantel Pamoate 180 mg (62.5mg pyrantel base per 180 mg of pyrantel pamoate)

  • PURPOSE

    Anthelmintic

  • Use

    for the treatment of Pinworms.

  • Warnings

    Abdominal cramps, nausea, vomiting, diarrhea, headache, or dizziness sometimes occur after taking this drug. If any of these conditions persist consult a doctor

    • If you are pregnant or have liver disease, don't take this product unless directed by a doctor.
  • Directions

    Adults, children 12 years of age and over, and children 2 years to under 12 years of age: Oral dosage is a single dose of 5 milligrams of pyrantel base per pound, or 11 milligrams per kilogram, of body weight. Do not exceed 1 gram (1000 mg).

    WeightDosage (Taken as a single dose)
    READ INSERT CAREFULLY BEFORE USE
    25-37 lb2 tablet
    38-62 lbs4 tablets
    63-87 lbs6 tablets
    88-112 lbs8 tablets
    113-137 lbs10 tablets
    138-162 lbs12 tablets
    163-187 lbs14 tablets
    over 188 lbs16 tablets

    Take only according to directions and don't exceed recommended dosage unless directed by a doctor. Medication should only be taken one time as a single dose; do not repeat treatment unless directed by a doctor. When one individual in house hold has pinworms, the entire household should be treated unless otherwise advised. See Warnings. If any worms other than pinworms are present before or after treatment, consult a doctor. If any symptoms or pinworms are still present after treatment consult a doctor

    • This product can be taken any time of day, with or without meals. It may be taken alone or with milk or fruit juice. Use of a laxative is not necessary prior to, during, or after medication.
  • KEEP OUT OF REACH OF CHILDREN

    Keep out of Reach of Children. In case of accidental overdose/ingestion contact a poison control center immediately.

  • Inactive Ingredients

    Croscarmellose Sodium, Crospovidone, Dicalcium Phosphate, Magnesium Stearate, Microcrystalline Cellulose

  • PRINCIPAL DISPLAY PANEL - 20 Tablet Blister Pack Carton

    VERMISOL
    TABLET

    Contains 20 Tablets

    PRINCIPAL DISPLAY PANEL - 20 Tablet Blister Pack Carton
  • INGREDIENTS AND APPEARANCE
    PYRANTEL PAMOATE 
    pyrantel pamoate tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58988-1760
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Pyrantel Pamoate (UNII: 81BK194Z5M) (Pyrantel - UNII:4QIH0N49E7) Pyrantel180 mg
    Inactive Ingredients
    Ingredient NameStrength
    Croscarmellose Sodium (UNII: M28OL1HH48)  
    Anhydrous Dibasic Calcium Phosphate (UNII: L11K75P92J)  
    Magnesium Stearate (UNII: 70097M6I30)  
    Microcrystalline Cellulose (UNII: OP1R32D61U)  
    Product Characteristics
    ColorYELLOWScoreno score
    ShapeROUNDSize11mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:58988-1760-12 in 1 CARTON09/27/2002
    110 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC MONOGRAPH FINALpart357B09/27/2002
    Labeler - ProMex LLC (789974388)